MAGOH and neoplasm: Similar results have previously been described for other types of cancer where both MAGOH and MAGOHB had to be depleted to gain a sufficient KD of MAGOH/MAGOHB protein levels to interrupt EJC function and to reduce tumor cell viability as well as Xenograft tumor growth in mice [20,22,24].